









市场行情
/
股票
/
nasdaq-cdna
/

CareDx Inc

CDNA

19.450USD

+0.260+1.35%

收盘 12/19, 16:00（美东）报价延迟15分钟

999.87M总市值

14.42市盈率 TTM



CareDx Inc

19.450

+0.260+1.35%

概览公司财务分析

概览

公司

财务

分析

关于 CareDx Inc 公司

CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.

CareDx Inc简介



公司代码CDNA

公司名称CareDx Inc

上市日期Jul 17, 2014

CEOHanna (John W)

员工数量644

证券类型Ordinary Share

年结日Jul 17

公司地址8000 Marina Blvd

城市BRISBANE

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编94005

电话14152872300

网址https://www.caredx.com/

公司代码CDNA

上市日期Jul 17, 2014

CEOHanna (John W)

CareDx Inc公司高管



名称

名称/职务

职务

持股

持股变动

Dr. Peter Maag, Ph.D.

Independent Director

298.28K

-3.24%

Mr. Michael D. Goldberg

Independent Chairman of the Board

145.40K

+1.22%

Dr. Frederick E. (Fred) Cohen, M.D.

Independent Director

144.69K

+9.13%

Ms. Jessica Meng

Chief Commercial Officer

109.63K

-4.11%

Mr. William A. (Bill) Hagstrom

Independent Director

43.41K

Mr. Nathan Smith

Chief Financial Officer

42.00K

Ms. Christine M. Cournoyer

Independent Director

38.58K

+45.71%

Mr. Suresh Gunasekaran

Director

27.45K

Mr. Jeffrey Adam Novack

General Counsel, Secretary

10.20K

-41.70%

Ms. Caroline Corner

Investor Relations

名称

名称/职务

职务

持股

持股变动

Dr. Peter Maag, Ph.D.

Independent Director

298.28K

-3.24%

Mr. Michael D. Goldberg

Independent Chairman of the Board

145.40K

+1.22%

Dr. Frederick E. (Fred) Cohen, M.D.

Independent Director

144.69K

+9.13%

Ms. Jessica Meng

Chief Commercial Officer

109.63K

-4.11%

Mr. William A. (Bill) Hagstrom

Independent Director

43.41K

Mr. Nathan Smith

Chief Financial Officer

42.00K

收入明细

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Testing Service revenue

62.03M

0.00%

Digital and other revenue

12.81M

0.00%

Product revenue

11.83M

0.00%

地区USD

名称

营收

占比

United States

81.64M

0.00%

Rest of the world

5.04M

0.00%

业务

地区

业务USD

名称

营收

占比

Testing Service revenue

62.03M

0.00%

Digital and other revenue

12.81M

0.00%

Product revenue

11.83M

0.00%

股东统计

更新时间: 11月17日周一

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

8.01%

The Vanguard Group, Inc.

7.27%

Baron Capital Management, Inc.

6.13%

State Street Investment Management (US)

4.99%

Ophir Asset Management Pty Ltd

4.27%

其他

69.32%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

8.01%

The Vanguard Group, Inc.

7.27%

Baron Capital Management, Inc.

6.13%

State Street Investment Management (US)

4.99%

Ophir Asset Management Pty Ltd

4.27%

其他

69.32%

股东类型

持股股东

占比

Investment Advisor/Hedge Fund

41.33%

Investment Advisor

35.53%

Hedge Fund

21.21%

Individual Investor

3.80%

Research Firm

3.27%

Pension Fund

0.59%

Bank and Trust

0.39%

Insurance Company

0.04%

机构持股



更新时间: 12月8日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q4

443

52.64M

115.22%

+43.46K

2025Q3

457

52.61M

115.96%

-1.80M

2025Q2

454

53.72M

112.39%

-1.85M

2025Q1

443

55.89M

106.19%

-3.01M

2024Q4

439

52.97M

108.30%

+1.05M

2024Q3

434

51.58M

120.50%

-825.62K

2024Q2

407

52.51M

127.45%

-1.22M

2024Q1

435

53.86M

132.45%

-14.73M

2023Q4

448

52.78M

128.80%

-2.04M

2023Q3

476

54.42M

142.26%

-1.69M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

4.07M

7.64%

-142.46K

-3.39%

Jun 30, 2025

The Vanguard Group, Inc.

4.90M

9.21%

+76.50K

+1.59%

Jun 30, 2025

Baron Capital Management, Inc.

2.44M

4.58%

+245.65K

+11.22%

Jun 30, 2025

State Street Investment Management (US)

2.18M

4.1%

-304.45K

-12.25%

Jun 30, 2025

Ophir Asset Management Pty Ltd

1.89M

3.56%

+274.63K

+16.97%

Jun 30, 2025

ARK Investment Management LLC

2.10M

3.95%

-247.22K

-10.53%

Jun 30, 2025

Amova Asset Management Co., Ltd.

1.24M

2.32%

-139.83K

-10.16%

Jun 30, 2025

Gagnon Securities LLC

2.13M

4.01%

+585.21K

+37.78%

Jul 17, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

ARK Genomic Revolution ETF

2.89%

ROBO Global Healthcare Technology & Innovation ETF

1.93%

Global X Genomics & Biotechnology ETF

0.87%

Franklin Genomic Advancements ETF

0.72%

State Street SPDR S&P Biotech ETF

0.34%

Direxion Daily S&P Biotech Bull 3X Shares

0.21%

iShares Micro-Cap ETF

0.16%

Fidelity Enhanced Small Cap ETF

0.11%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.11%

Principal U.S. Small-Cap ETF

0.1%

ARK Genomic Revolution ETF

占比2.89%

ROBO Global Healthcare Technology & Innovation ETF

占比1.93%

Global X Genomics & Biotechnology ETF

占比0.87%

Franklin Genomic Advancements ETF

占比0.72%

State Street SPDR S&P Biotech ETF

占比0.34%

Direxion Daily S&P Biotech Bull 3X Shares

占比0.21%

iShares Micro-Cap ETF

占比0.16%

Fidelity Enhanced Small Cap ETF

占比0.11%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

占比0.11%

Principal U.S. Small-Cap ETF

占比0.1%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

CareDx Inc的前五大股东是谁？



CareDx Inc 的前五大股东如下：
BlackRock Institutional Trust Company, N.A.持有股份：4.07M，占总股份比例：7.64%。
The Vanguard Group, Inc.持有股份：4.90M，占总股份比例：9.21%。
Baron Capital Management, Inc.持有股份：2.44M，占总股份比例：4.58%。
State Street Investment Management (US)持有股份：2.18M，占总股份比例：4.10%。
Ophir Asset Management Pty Ltd持有股份：1.89M，占总股份比例：3.56%。